These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18281368)

  • 21. Treatment of scleroderma lung disease: comment on the article by Steen et al.
    Fairfax MJ
    Arthritis Rheum; 1995 Sep; 38(9):1345. PubMed ID: 7575736
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful use of rituximab in a patient with recalcitrant livedoid vasculopathy.
    Zeni P; Finger E; Scheinberg MA
    Ann Rheum Dis; 2008 Jul; 67(7):1055-6. PubMed ID: 18556452
    [No Abstract]   [Full Text] [Related]  

  • 23. Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
    Burr ML; Malaviya AP; Gaston JH; Carmichael AJ; Ostör AJ
    Rheumatology (Oxford); 2008 May; 47(5):738-9. PubMed ID: 18375402
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of rituximab in a patient with active rheumatoid arthritis and chronic disseminated pulmonary aspergillosis and history of tuberculosis.
    Jung N; Owczarczyk K; Hellmann M; Lehmann C; Fätkenheuer G; Hallek M; Rubbert A
    Rheumatology (Oxford); 2008 Jun; 47(6):932-3. PubMed ID: 18417524
    [No Abstract]   [Full Text] [Related]  

  • 25. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
    van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ
    Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744
    [No Abstract]   [Full Text] [Related]  

  • 26. Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura.
    Carella AM; D'Arena G; Greco MM; Nobile M; Cascavilla N
    Bone Marrow Transplant; 2008 Jun; 41(12):1063-5. PubMed ID: 18317457
    [No Abstract]   [Full Text] [Related]  

  • 27. Lack of efficacy of rituximab in Felty's syndrome.
    Sordet C; Gottenberg JE; Hellmich B; Kieffer P; Mariette X; Sibilia J
    Ann Rheum Dis; 2005 Feb; 64(2):332-3. PubMed ID: 15647445
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rituximab: a new therapeutic arm in refractory rheumatoid arthritis: about one case].
    Abdelmoula LC; Testouri N; Ben Hadj Yahia C; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
    Tunis Med; 2008 Sep; 86(9):841-2. PubMed ID: 19472790
    [No Abstract]   [Full Text] [Related]  

  • 29. Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
    Narváez J; Díaz-Torné C; Juanola X; Geli C; Llobet JM; Nolla JM; Díaz-López C
    Ann Rheum Dis; 2009 Apr; 68(4):607-8. PubMed ID: 19286909
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Pagel JM; Lionberger J; Gopal AK; Sabath DE; Loeb K
    Am J Hematol; 2007 Dec; 82(12):1121-2. PubMed ID: 17696200
    [No Abstract]   [Full Text] [Related]  

  • 31. Scleroderma lung disease: evolving understanding in light of newer studies.
    Antoniou KM; Wells AU
    Curr Opin Rheumatol; 2008 Nov; 20(6):686-91. PubMed ID: 18946329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.
    Teng YK; Levarht EW; Toes RE; Huizinga TW; van Laar JM
    Ann Rheum Dis; 2009 Jun; 68(6):1011-6. PubMed ID: 18647852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membranous glomerulopathy associated with rheumatoid arthritis may respond to rituximab.
    Pixley J; Wolf B; O'Neill W
    Scand J Rheumatol; 2008; 37(4):313-4. PubMed ID: 18612934
    [No Abstract]   [Full Text] [Related]  

  • 34. Comment on: a case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy response.
    Dunkley L; Green M; Gough A
    Rheumatology (Oxford); 2007 Oct; 46(10):1628-9. PubMed ID: 17766999
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful treatment of cardiac sarcoidosis with infliximab.
    Barnabe C; McMeekin J; Howarth A; Martin L
    J Rheumatol; 2008 Aug; 35(8):1686-7. PubMed ID: 18671332
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients.
    Leroux G; Costedoat-Chalumeau N; Brihaye B; Cohen-Bittan J; Amoura Z; Haroche J; Limal N; Bletry O; Piette JC
    Arthritis Rheum; 2009 May; 61(5):577-82. PubMed ID: 19405005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum of fibrosing diffuse parenchymal lung disease.
    Morgenthau AS; Padilla ML
    Mt Sinai J Med; 2009 Feb; 76(1):2-23. PubMed ID: 19170214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical improvement in antiphospholipid syndrome after rituximab therapy.
    Adamson R; Sangle S; Kaul A; Hughes GR; D'Cruz DP
    J Clin Rheumatol; 2008 Dec; 14(6):359-60. PubMed ID: 19033874
    [No Abstract]   [Full Text] [Related]  

  • 39. Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab.
    Malesci D; La Montagna G
    Rheumatology (Oxford); 2008 May; 47(5):734-5. PubMed ID: 18326535
    [No Abstract]   [Full Text] [Related]  

  • 40. A case of Raynaud's phenomenon in mixed connective tissue disease responding to rituximab therapy.
    Haroon M; O'Gradaigh D; Foley-Nolan D
    Rheumatology (Oxford); 2007 Apr; 46(4):718-9. PubMed ID: 17289791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.